TRIZIVIR

Product NDC: 49702-217
11-digit product format: 497020217
Labeler code: 49702
Product ID: 49702-217_1001c7d9-56da-44f8-ba9c-a45be7a239b7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: abacavir sulfate, lamivudine, and zidovudine
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: ViiV Healthcare Company
Application: NDA021205
Marketing category: NDA
Marketing start: 2010-11-02
Marketing end: 0000-00-00
Substance: ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE
Active strength: 300 mg/1; mg/1; mg/1
Pharmacologic classes: Cytochrome P450 1A1 Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	49702-217		D	Discontinued by firm		2026-08-11
excluded package	package	49702-217	49702-217-18	D	Discontinued by firm		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	49702-217-18	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	49702-217-18	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	49702-217-18	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	49702-217-18	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	49702-217-18	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	49702-217-18	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	49702-217-18	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	49702-217-18	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	49702-217-18	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021205-001	TRIZIVIR	ABACAVIR SULFATE; LAMIVUDINE; ZIDOVUDINE	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / ORAL		RLD	2000-11-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL		RLD	2000-11-14	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021205-001	TRIZIVIR	EQ 300MG BASE;150MG;300MG	TABLET / ORAL	AB	RLD, RS	2000-11-14	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021205-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021205-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021205-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021205-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021205-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021205-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021205-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021205-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021205-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021205-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021205-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021205-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021205-001	AB	1	`ea99ee380514…`
2023-12-20 04:57 UTC	2023-12	N021205-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021205-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021205-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021205-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021205-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021205-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021205-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021205-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021205-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021205-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021205-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
aaa99659-c62c-7281-d402-9590409850c2	Product name	6	20260128
a02e6d35-8cc4-a80a-fd4d-d3ec16f69b8e	Product name	8	20250626
4ef90d80-1289-4267-a2bb-01c741d1208f	Product name	1	20230829
72dcca4e-6eae-4149-a92b-264c2a07004f	Product name	1	20230808
3832141c-c294-474a-9473-1052c891450e	Product name	2	20230105
320f244d-8b4e-4893-9f14-104b2a8e0aaf	Product name	2	20201007
7ff71f22-5b66-4a3d-bf64-671893a6409d	Product name	2	20201007
3644e9cf-6f4d-4b63-b875-6a4b5187c47e	Product name	1	20190703
0e579b5c-f0b5-e690-466e-4a5e809e2c68	Product name	3	20190627
6f122144-2ceb-48fa-a906-0d2eb742717e	Product name	1	20190624
8051c8a3-aee0-45a2-a236-8ee3f9e65f67	Product name	1	20181211
fbdbfbef-2c33-0298-4fef-f6693e670fe1	Product name	7	20181210
d07e0b9e-e041-41dc-942a-a2a6601dc221	Product name	1	20181029
e1e3cf65-28b8-ebf3-c11f-d11a82e0862a	Product name	4	20180604
af19b329-4f44-cd81-491a-fbb7fe7a079f	Product name	2	20151013
c873f14e-2add-4d53-b9b3-bf775efd3702	Product name	1	20150325
e1098f43-eafb-82a0-ef30-575f1d8189b0	Product name	2	20150227
9ceb457b-0c09-9326-bbca-f296202d412c	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
49702-217-18	EA - Each	49702-217	562976c8-cb97-4fd3-b786-3adc1a78f0df	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ABACAVIR SULFATE	ACTIVE INGREDIENT	J220T4J9Q2	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
ZIDOVUDINE	ACTIVE INGREDIENT	4B9XT59T7S	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
ABACAVIR	ACTIVE MOIETY	WR2TIP26VS	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
ZIDOVUDINE	ACTIVE MOIETY	4B9XT59T7S	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY]	16
ABACAVIR SULFATE	ACTIVE INGREDIENT	J220T4J9Q2	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
LAMIVUDINE	ACTIVE INGREDIENT	2T8Q726O95	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
ZIDOVUDINE	ACTIVE INGREDIENT	4B9XT59T7S	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
ABACAVIR	ACTIVE MOIETY	WR2TIP26VS	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
LAMIVUDINE	ACTIVE MOIETY	2T8Q726O95	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
ZIDOVUDINE	ACTIVE MOIETY	4B9XT59T7S	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
J220T4J9Q2	ABACAVIR SULFATE	188062-50-2	ABACAVIR SULFATE
2T8Q726O95	LAMIVUDINE	134678-17-4	LAMIVUDINE
4B9XT59T7S	ZIDOVUDINE	30516-87-1	ZIDOVUDINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
307650	abacavir sulfate 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet	PSN	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
285028	TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet	PSN	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
285028	abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir]	SBD	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
307650	abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet	SCD	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
307650	abacavir (as abacavir sulfate) 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet	SY	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
307650	abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet	SY	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
285028	abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet [Trizivir]	SY	3354e50f-4dc5-413f-b5ae-87353ab8913d	2
285028	Trizivir (abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG) Oral Tablet	SY	3354e50f-4dc5-413f-b5ae-87353ab8913d	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
49702-217-18	49702021718	60 TABLET, FILM COATED in 1 BOTTLE (49702-217-18)	2010-11-02	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TRIZIVIR	ViiV Healthcare Company	2024-03-26	HUMAN PRESCRIPTION DRUG LABEL	28
TRIZIVIR	State of Florida DOH Central Pharmacy	2014-04-24	HUMAN PRESCRIPTION DRUG LABEL	2